Evidence map›Paper›PMID 22973012›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Live imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.

Ferdinand Kaya, Abdelkrim Mannioui, Albert Chesneau, Sowmya Sekizar, Emmanuelle Maillard, Chantal Ballagny, Ludivine Houel-Renault, David Dupasquier, Odile Bronchain, Isabelle Holtzmann and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structure and Dynamics of ThreeInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Bruton's Tyrosine Kinase Inhibition Promotes Myelin Repair.Brain plasticity (Amsterdam, Netherlands) · 2020
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Ferdinand KayaCNRS UPR 3294, Neurobiology and Development, Université Paris Sud XI, 91405 Orsay, France.
Abdelkrim Mannioui
Albert Chesneau
Sowmya Sekizar
Emmanuelle Maillard
Chantal Ballagny
Ludivine Houel-Renault
David Dupasquier
Odile Bronchain
Isabelle Holtzmann
Anne Desmazieres
Jean-Léon Thomas
Barbara A Demeneix
Peter J Brophy
Bernard Zalc
Andre Mazabraud
Centre National de la Recherche Scientifique · FRSorbonne Université · FRUniversité Paris-Sud · FRInserm · FRUniversity of Edinburgh · GBWatchfrog (France) · FRYale University · US

Funding

Wellcome Trust 089000
6 · The paper itself

Abstract

Live imaging studies of the processes of demyelination and remyelination have so far been technically limited in mammals. We have thus generated a Xenopus laevis transgenic line allowing live imaging and conditional ablation of myelinating oligodendrocytes throughout the CNS. In these transgenic pMBP-eGFP-NTR tadpoles the myelin basic protein (MBP) regulatory sequences, specific to mature oligodendrocytes, are used to drive expression of an eGFP (enhanced green fluorescent protein) reporter fused to the Escherichia coli nitroreductase (NTR) selection enzyme. This enzyme converts the innocuous prodrug metronidazole (MTZ) to a cytotoxin. Using two-photon imaging in vivo, we show that pMBP-eGFP-NTR tadpoles display a graded oligodendrocyte ablation in response to MTZ, which depends on the exposure time to MTZ. MTZ-induced cell death was restricted to oligodendrocytes, without detectable axonal damage. After cessation of MTZ treatment, remyelination proceeded spontaneously, but was strongly accelerated by retinoic acid. Altogether, these features establish the Xenopus pMBP-eGFP-NTR line as a novel in vivo model for the study of demyelination/remyelination processes and for large-scale screens of therapeutic agents promoting myelin repair.

Indexed as

Disease Models, AnimalAnimalsDemyelinating DiseasesHumansMicroscopy, Fluorescence, MultiphotonNerve RegenerationXenopus laevis

Identifiers

PMID22973012
PMCPMC3460536
OpenAlexW2129448532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.